143 related articles for article (PubMed ID: 38667272)
1. Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
Borsi E; Vigliotta I; Poletti A; Mazzocchetti G; Solli V; Zazzeroni L; Martello M; Armuzzi S; Taurisano B; Kanapari A; Pistis I; Zamagni E; Pantani L; Rocchi S; Mancuso K; Tacchetti P; Rizzello I; Rizzi S; Dan E; Sinigaglia B; Cavo M; Terragna C
Cells; 2024 Apr; 13(8):. PubMed ID: 38667272
[TBL] [Abstract][Full Text] [Related]
2. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.
Mouhieddine TH; Sperling AS; Redd R; Park J; Leventhal M; Gibson CJ; Manier S; Nassar AH; Capelletti M; Huynh D; Bustoros M; Sklavenitis-Pistofidis R; Tahri S; Hornburg K; Dumke H; Itani MM; Boehner CJ; Liu CJ; AlDubayan SH; Reardon B; Van Allen EM; Keats JJ; Stewart C; Mehr S; Auclair D; Schlossman RL; Munshi NC; Anderson KC; Steensma DP; Laubach JP; Richardson PG; Ritz J; Ebert BL; Soiffer RJ; Trippa L; Getz G; Neuberg DS; Ghobrial IM
Nat Commun; 2020 Jun; 11(1):2996. PubMed ID: 32533060
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias.
Testa S; Kumar J; Goodell AJ; Zehnder JL; Alexander KM; Sidana S; Arai S; Witteles RM; Liedtke M
Semin Oncol; 2022 Dec; 49(6):465-475. PubMed ID: 36503855
[TBL] [Abstract][Full Text] [Related]
4. Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation.
Ortmann CA; Dorsheimer L; Abou-El-Ardat K; Hoffrichter J; Assmus B; Bonig H; Scholz A; Pfeifer H; Martin H; Schmid T; Brüne B; Scheich S; Steffen B; Riemann J; Hermann S; Dukat A; Bug G; Brandts CH; Wagner S; Serve H; Rieger MA
Cell Rep; 2019 May; 27(7):2022-2028.e3. PubMed ID: 31091442
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
6. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
7. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
8. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis with
Stelmach P; Richter S; Sauer S; Fabre MA; Gu M; Rohde C; Janssen M; Liebers N; Proynova R; Weinhold N; Raab MS; Goldschmidt H; Besenbeck B; Pavel P; Laier S; Trumpp A; Dietrich S; Vassiliou GS; Müller-Tidow C
Haematologica; 2023 Dec; 108(12):3308-3320. PubMed ID: 37381752
[TBL] [Abstract][Full Text] [Related]
10. Targeted, Amplicon-Based, Next-Generation Sequencing to Detect Age-Related Clonal Hematopoiesis.
Snetsinger B; Ferrone CK; Rauh MJ
Methods Mol Biol; 2019; 2045():167-180. PubMed ID: 30941718
[TBL] [Abstract][Full Text] [Related]
11. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
Gibson CJ; Lindsley RC; Tchekmedyian V; Mar BG; Shi J; Jaiswal S; Bosworth A; Francisco L; He J; Bansal A; Morgan EA; Lacasce AS; Freedman AS; Fisher DC; Jacobsen E; Armand P; Alyea EP; Koreth J; Ho V; Soiffer RJ; Antin JH; Ritz J; Nikiforow S; Forman SJ; Michor F; Neuberg D; Bhatia R; Bhatia S; Ebert BL
J Clin Oncol; 2017 May; 35(14):1598-1605. PubMed ID: 28068180
[TBL] [Abstract][Full Text] [Related]
12. Clonal Hematopoiesis in Young Women Treated for Breast Cancer.
Gibson CJ; Fell G; Sella T; Sperling AS; Snow C; Rosenberg SM; Kirkner G; Patel A; Dillon D; Bick AG; Neuberg D; Partridge AH; Miller PG
Clin Cancer Res; 2023 Jul; 29(13):2551-2558. PubMed ID: 37115512
[TBL] [Abstract][Full Text] [Related]
13. Poor mobilization of autologous CD34
Gifford G; Hesson L; Wong JWH; Carroll A; Gabrielli S; Bai L; Xia W; Stevenson W; Greenwood M
Br J Haematol; 2021 May; 193(4):841-844. PubMed ID: 33481245
[TBL] [Abstract][Full Text] [Related]
14. High frequency of clonal hematopoiesis in Erdheim-Chester disease.
Cohen Aubart F; Roos-Weil D; Armand M; Marceau-Renaut A; Emile JF; Duployez N; Charlotte F; Poulain S; Lhote R; Hélias-Rodzewicz Z; Della-Valle V; Bernard O; Maloum K; Nguyen-Khac F; Donadieu J; Amoura Z; Abdel-Wahab O; Haroche J
Blood; 2021 Jan; 137(4):485-492. PubMed ID: 33067622
[TBL] [Abstract][Full Text] [Related]
15. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.
Wiedmeier JE; Kato C; Zhang Z; Lee H; Dunlap J; Nutt E; Rattray R; McKay S; Eide C; Press R; Mori M; Druker B; Dao KH
Exp Hematol; 2016 Sep; 44(9):857-865.e5. PubMed ID: 27235757
[TBL] [Abstract][Full Text] [Related]
16. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract][Full Text] [Related]
17. Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.
Albertí-Servera L; Demeyer S; Govaerts I; Swings T; De Bie J; Gielen O; Brociner M; Michaux L; Maertens J; Uyttebroeck A; De Keersmaecker K; Boeckx N; Segers H; Cools J
Blood; 2021 Feb; 137(6):801-811. PubMed ID: 32812017
[TBL] [Abstract][Full Text] [Related]
18. Lineage restriction analyses in CHIP indicate myeloid bias for
Buscarlet M; Provost S; Zada YF; Bourgoin V; Mollica L; Dubé MP; Busque L
Blood; 2018 Jul; 132(3):277-280. PubMed ID: 29764839
[TBL] [Abstract][Full Text] [Related]
19. Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
Marshall CH; Gondek LP; Luo J; Antonarakis ES
Cancer Res; 2022 Nov; 82(22):4107-4113. PubMed ID: 36040522
[TBL] [Abstract][Full Text] [Related]
20. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
